USANA Health Sciences (USNA) Tops Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts USNA Hot Sheet
Price: $14.14 -1.39%
EPS Growth %: +386.7%
Financial Fact:
Associate incentives: 112.82M
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: +386.7%
Financial Fact:
Associate incentives: 112.82M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
USANA Health Sciences (NYSE: USNA) reported Q1 EPS of $1.15, $0.01 better than the analyst estimate of $1.14. Revenue for the quarter came in at $273 million versus the consensus estimate of $267.31 million.
GUIDANCE:
USANA Health Sciences sees FY2022 EPS of $5.00-$5.70, versus the consensus of $5.46. USANA Health Sciences sees FY2022 revenue of $1.1-1.2 billion, versus the consensus of $1.14 billion.
For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Corpay agrees to $100M FTC settlement over marketing practices
- Investing.com’s stocks of the week
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
